Clinical Trials
Below is a list of all clinical trials.
| Breast |
|---|
|
CTSU S0221 - Continuous Schedule Ac + G Vs. Q 2 Week Schedule Ac, Followed By Paclitaxel Given Either Every 2 Weeks Or Weekly For 12 Weeks As Post Operative Adjuvant Therapy In Node Positive Or High Risk Node Negative Breast Cancer
|
|
CALGB 40502 - Phase Iii Randomized Study Of Paclitaxel Versus Paclitaxel Albumin Stabilized Nanoparticle Formulation Versus Ixabepilone With Or Without Bevacizumab In Patients With Stage Iiic Or Iv Breast Cancer (The Ixabepilone Arm Has Been Closed As Of 8/15/11)
|
|
NSABP-47 - Chemotherapy With Or Without Trastuzumab After Surgery In Treating Women With Invasive Breast Cancer
|
|
RTOG 1005 - Higher Dose Radiation Therapy Or Standard Radiation Therapy In Treating Patients With Early Stage Breast Cancer That Was Removed By Surgery
|
| Gastrointestinal Malignancies Stromal Tumors |
|
CALGB 80701 - Everolimus And Octreotide With Or Without Bevacizumab In Treating Patients With Locally Advanced Or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery
|
There are many "yardsticks" to measure your health & health IQ.
Try some of our Calculators, or take a Quiz Get the facts on having a healthy pregnancy.
Get the latest Health Information from our extensive online library.
If you desire to good health, Mercy's Health News Resource Center can help you!
Mercy Medical Center is the FIRST hospital in northeast Ohio to achieve CAP 15189SM accreditation.
Mercy Department of Pathology and Laboratory Medicine achieved the College of American Pathologists CAP 15189SM accreditation based on quality standards outlined by the International Organization for Standardization. Accreditation focuses on improved patient safety and risk reduction, outlining standards for quality and competence particular to medical laboratories.
Mercy laboratory professionals and pathologists work behind the scenes to accurately and efficiently analyze fluids and tissues to help physicians diagnose disease, manage treatment and determine a person's risk for developing a medical condition.
Mercy Medical Center recently became the first hospital in Northeast Ohio to achieve the College of American Pathologists CAP 15189(SM) accreditation based on the quality standards outlined by the International Organization for Standardization (ISO). The accreditation focuses on improved patient safety and risk reduction, outlining standards for quality and competence particular to medical laboratories.
Pictured are Jeffrey L. Smith, Mercy Medical Center Senior Vice President and Chief Operating Officer; Aida Safar, M.D., FCAP, medical director for the Mercy Department of Pathology and Laboratory Medicine; Michael Grilliot, National Account Manager for CAP 15189 (College of American Pathology); Thomas E. Cecconi, President and Chief Executive Officer of Mercy Medical Center; Mary Ann Burich-Boccia, MBA, MT (ASCP), SBB, administrative director of the Mercy Department of Pathology and Laboratory Medicine and Gayle Brown, laboratory coordinator at Mercy.
For your convenience, Mercy offers outpatient laboratory services at the following locations:
MERCY MEDICAL CENTER
1320 Mercy Drive NW, Canton
(330) 489-1300 - Central Scheduling
(330) 489-1075 - Laboratory
6:45 a.m. - 6:00 p.m. (Monday, Tuesday & Thursday)
6:45 a.m. - 5:00 p.m. (Wednesday & Friday)
7:00 a.m. - 12:00 p.m. (Saturday)
No Appointment Necessary
MERCY HEALTH CENTER OF LAKE
11932 King Church Avenue NW, Uniontown
Phone: (330) 877-5000
7:00 a.m. - 4:00 p.m. (Monday through Friday)
No Appointment Necessary
MERCY HEALTH CENTER OF NORTH CANTON
6200 Whipple Avenue NW, North Canton
(330) 489-1300 - Central Scheduling
(330) 966-4979 - Laboratory
7:00 a.m. - 10:00 p.m. (Monday through Saturday)
8:00 a.m. - 10:00 p.m. (Sunday)
No Appointment Necessary
MERCY HEALTH CENTER OF JACKSON
7337 Caritas Circle NW, Massillon
(330) 830-6110 - Facility
7:00 a.m. - 9:00 p.m. (Monday through Friday)
9:00 a.m. - 5:00 p.m. (Saturday and Sunday)
No Appointment Necessary
MERCY HEALTH CENTER OF PLAIN
1811 Schneider Ave. NE, Canton
(330) 494-6480
8:00 a.m. - 7:00 p.m. (Monday through Friday)
9:00 a.m. - 2:00 p.m. (Saturday)
No Appointment Necessary
MERCY LABORATORY SERVICES AT HARRISON
1445 Harrison Professional Center
South Building, Suite 204, Canton
Phone: (330) 452-7994 - Laboratory
8:00 a.m. - 4:15 p.m. (Monday, Tuesday,
Thursday & Friday)
8:00 a.m. - 12:15 p.m. (Wednesday)
Closed for Lunch (12:30 p.m. - 1:30 p.m.)
No Appointment Necessary
MERCY LABORATORY SERVICES AT LITTLE FLOWER
211 – 15th Street NW, Canton
Phone: (330) 588-3354
8:00 a.m. - 4:00 p.m. (Monday, Tuesday, Thursday & Friday)
8:00 a.m. - 12:00 p.m. (Wednesday)
Closed for Lunch (12:00 p.m. - 1:00 p.m.)
No Appointment Necessary
MERCY HEALTH CENTER OF LOUISVILLE
1302 West Main Street, Louisville
Phone: (330) 875-0096 - Laboratory
7:00 a.m. - 4:00 p.m. (Monday, Tuesday & Friday)
7:00 a.m. - 12:00 p.m. (Wednesday)
7:00 a.m. - 5:00 p.m. (Thursday)
Closed for Lunch (12:00 p.m. - 1:00 p.m.)
No Appointment Necessary
MERCY HEALTH CENTER OF CARROLL COUNTY
125 Canton Road NW, Carrollton
Phone: (330) 627-7641
7:00 a.m. - 9:00 p.m. (Monday through Friday)
9:00 a.m. - 5:00 p.m. (Saturday and Sunday)
No Appointment Necessary
MERCY HEALTH CENTER OF TUSCARAWAS COUNTY
1031 West High Ave., New Philadelphia
Phone: (330) 365-5100
7:00 a.m. - 9:00 p.m. (Monday through Friday)
9:00 a.m. - 5:00 p.m. (Saturday and Sunday)
No Appointment Necessary
Sites Performing Special Services:
PRESCHOOL AGE DRAWS
Carrollton
North Canton
Mercy Medical Center
Harrison
Little Flower
Jackson
Tuscarawas
RSV COLLECTION
Mercy Health Center of North Canton
ADULT CATH URINES
Mercy Medical Center
PEDIATRIC CATH URINES
Mercy Medical Center
BLOOD OBTAINED FROM LINE DRAWS
Mercy Medical Center
For questions contact:
Steve Boger........................... (330) 489-1223
Sandi Boron........................... (330) 489-1111, ext. 4235
Pathology Services and Clinical Laboratory oversight is provided by ModernPath, Inc.
Breast Cancer
The Mercy Cancer Center takes great pride in the care we deliver. To monitor the quality of that care, we track specific quality measures and compare them to benchmark measures. We think consumers have the right to know this information so you can draw your own conclusions regarding your health care choices.
Quality data can be confusing so Mercy Cancer Center is taking the initiative to publish this information in an understandable format. We invite you to review this information and please call us if you have questions. We are committed to providing the very highest quality cancer care.
Breast cancer quality data is the first to be published. Please refer back to our web site in the coming months to see quality data for other cancer diagnoses.
Breast Cancer Quality Data
Mammography MQSA Certification
5-Year Breast Cancer Survival Rate
Percentage of Early Stage Breast Cancer
Minimally Invasive Breast Biopsy
Breast Conservation Surgery
Radiation Treatment with Breast Conservation Surgery
Mammography MQSA Certification
When you have a mammogram, you want to be confident that your healthcare facility is certified and meets the highest standards for personnel qualifications, equipment, radiation dose, quality assurance programs, recordkeeping and reporting. Congress enacted the Mammography Quality Standards Act (MQSA) to ensure women have access to quality mammography services. To become MQSA certified, mammography facilities must employ only registered mammography technologists and undergo a thorough annual inspection conducted by federally trained and certified State surveyors who review over 50 quality indicators.
Mercy
National
% Annual Inspections with No
MQSA Violations
100%*
76.4%
100% at all Mercy locations: Main Campus, North Canton, Jackson, Louisville, Carrollton
5-Year Breast Cancer Survival Rate
Overall survival from breast cancer is the most important goal. Survival is tied to the stage of the disease at the time of diagnosis. Five-year survival rate (the percentage of women who are still alive five years after diagnosis) is the standard measurement that is used to express the outlook for your disease. The cancer stage - noted as a number from 0 to IV - is based on the size of the tumor and whether the cancer has spread to the lymph nodes. The lower the number, the less disease. It is important to remember that these survival rates are based on averages. Some women with advanced breast cancer live significantly longer than seven years and researchers are constantly developing new treatment alternatives to prolong breast cancer survival.
Mercy
National
Combined Stage 0-II
87.4%
87.1%
Combined Stage III-IV
40.9%
42.9%
Combined All Stages
82.7%
82.3%
Source: CIRF Cancer Registry Reported to National Cancer Database
Percentage of Early Stage Breast Cancer
Because disease stage at diagnosis significantly influences survival, it is critical to diagnose breast cancers as early as possible. Mercy Cancer Center tracks the percentage of breast cancers diagnosed at Stage 0 through II which offer women the greatest advantage of long-term survival.
Mercy
National
% of Breast Cancers
Diagnosed at
Stage 0-II
91.4%
83.2%
Source: CIRF Cancer Registry Reported to National Cancer Database
Minimally Invasive Breast Biopsy
Minimally invasive breast biopsy involves taking a core of breast tissue rather than performing an incision to remove a breast tissue sample. Research shows that conventional surgical biopsies present certain disadvantages including prolonged time to diagnosis, breast scarring, increased pain for the patient and substantially higher costs than the minimally invasive options. It is important to note that not all breast lesions can be biopsied by minimally invasive techniques, but it is a biopsy technique that should be considered when appropriate.
Mercy
National
% of Minimally Invasive
Breast Biopsies
75.6%
65%
Source: CIRF Cancer Registry Reported to National Cancer Database
Breast Conservation Surgery
The National Institutes of Health has recommended breast conservation surgery (lumpectomy) rather than mastectomy for the majority of women with early stage, invasive breast cancer. Lumpectomy decreases the potential for adverse effects from surgery and minimizes physical alterations. More importantly, studies have proven that long-term survival is no different. Despite these facts, some women still opt for mastectomy.
Mercy
National
% Breast Conservation
Surgery
65.8%
65%
Source: CIRF Cancer Registry and Oncology Roundtable Survey
Radiation Treatment with Breast Conservation Surgery
The purpose of breast conservation therapy is to give women the same cure rate they would have if they were treated with a mastectomy but to leave the breast intact, with an appearance and texture as close as possible to what they had before treatment. Breast conservation surgery (lumpectomy) is almost always followed by radiation therapy. The purpose of the radiation treatment is to decrease the recurrence of breast cancer in the remaining breast tissue. Years of clinical study have proven that breast conservation therapy offers the same cure rate as mastectomy.
Mercy
National
% Patients with Breast Conserving
Surgery that Received Radiation
93.4%
85.0%
Source: CIRF Cancer Registry and NCCN 9th Annual Conference
Other Measures of Quality
The mark of excellence can also be defined by other important quality indicators that are not demonstrated through statistics. Mercy Cancer Center is committed to excellence in cancer care as evidenced by:
Three-year accreditation with accommodation as a Comprehensive Community Hospital Cancer Center by the American College of Surgeons’ Commission on Cancer
Timely and accurate submission of all patient data to the National Cancer Data Base
Accreditation of Stereotactic Breast Biopsy Services by the American College of Radiology
Bi-weekly multidisciplinary Breast Cancer Conferences
Weekly multidisciplinary Tumor Conferences
Mercy Medical Center Medical Staff comprised of 94% Board Certified Physicians
